Linagliptin and Metformin Extended-Release Tablets and Siltuximab Intravenous
Determining the interaction of Linagliptin and Metformin Extended-Release Tablets and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Linagliptin and Metformin Extended-Release Tablets-Silvadene
- Linagliptin and Metformin Extended-Release Tablets-Silvadene Topical
- Linagliptin and Metformin Extended-Release Tablets-SilvaSorb
- Linagliptin and Metformin Extended-Release Tablets-Silver
- Linagliptin and Metformin Extended-Release Tablets-Silver Nitrate
- Linagliptin and Metformin Extended-Release Tablets-Silver Nitrate Applicators
- Siltuximab Intravenous-Linagliptin and Metformin Tablets
- Siltuximab Intravenous-Lincocin
- Siltuximab Intravenous-Lincomycin
- Siltuximab Intravenous-Lincomycin Hydrochloride
- Siltuximab Intravenous-Lincomycin Injection
- Siltuximab Intravenous-Lincomycin Oral, Injection